| UniProt ID | MCA3_HUMAN | |
|---|---|---|
| UniProt AC | O43324 | |
| Protein Name | Eukaryotic translation elongation factor 1 epsilon-1 | |
| Gene Name | EEF1E1 | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 174 | |
| Subcellular Localization | Cytoplasm . Cytoplasm, cytosol . Nucleus . Cytoplasmic under growth arrest conditions. Translocated into the nucleus when growth resumes (S phase) and following DNA damage. | |
| Protein Description | Positive modulator of ATM response to DNA damage.. | |
| Protein Sequence | MAAAAELSLLEKSLGLSKGNKYSAQGERQIPVLQTNNGPSLTGLTTIAAHLVKQANKEYLLGSTAEEKAIVQQWLEYRVTQVDGHSSKNDIHTLLKDLNSYLEDKVYLTGYNFTLADILLYYGLHRFIVDLTVQEKEKYLNVSRWFCHIQHYPGIRQHLSSVVFIKNRLYTNSH | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 2 | Acetylation | ------MAAAAELSL ------CCHHHHHHH | 13.05 | - | |
| 8 | Phosphorylation | MAAAAELSLLEKSLG CCHHHHHHHHHHHHC | 23.55 | 20068231 | |
| 12 | Ubiquitination | AELSLLEKSLGLSKG HHHHHHHHHHCCCCC | 51.45 | 22817900 | |
| 12 | Acetylation | AELSLLEKSLGLSKG HHHHHHHHHHCCCCC | 51.45 | 19608861 | |
| 12 | 2-Hydroxyisobutyrylation | AELSLLEKSLGLSKG HHHHHHHHHHCCCCC | 51.45 | - | |
| 12 | Ubiquitination | AELSLLEKSLGLSKG HHHHHHHHHHCCCCC | 51.45 | 21890473 | |
| 13 | Phosphorylation | ELSLLEKSLGLSKGN HHHHHHHHHCCCCCC | 20.49 | 24719451 | |
| 17 | Phosphorylation | LEKSLGLSKGNKYSA HHHHHCCCCCCCCCC | 36.40 | 28674151 | |
| 18 | Ubiquitination | EKSLGLSKGNKYSAQ HHHHCCCCCCCCCCC | 72.11 | 27667366 | |
| 21 | Acetylation | LGLSKGNKYSAQGER HCCCCCCCCCCCCCE | 49.61 | 23749302 | |
| 22 | Phosphorylation | GLSKGNKYSAQGERQ CCCCCCCCCCCCCEE | 17.15 | 24719451 | |
| 23 | Phosphorylation | LSKGNKYSAQGERQI CCCCCCCCCCCCEEC | 18.74 | 24719451 | |
| 35 | Phosphorylation | RQIPVLQTNNGPSLT EECCEEECCCCCCCC | 26.87 | 26846344 | |
| 40 | Phosphorylation | LQTNNGPSLTGLTTI EECCCCCCCCHHHHH | 39.71 | 26846344 | |
| 42 | Phosphorylation | TNNGPSLTGLTTIAA CCCCCCCCHHHHHHH | 34.19 | 26846344 | |
| 45 | Phosphorylation | GPSLTGLTTIAAHLV CCCCCHHHHHHHHHH | 19.94 | 26846344 | |
| 46 | Phosphorylation | PSLTGLTTIAAHLVK CCCCHHHHHHHHHHH | 17.42 | 26846344 | |
| 53 | Ubiquitination | TIAAHLVKQANKEYL HHHHHHHHHHCHHHH | 50.48 | 21906983 | |
| 57 | Acetylation | HLVKQANKEYLLGST HHHHHHCHHHHCCCC | 51.23 | 26051181 | |
| 57 | Ubiquitination | HLVKQANKEYLLGST HHHHHHCHHHHCCCC | 51.23 | 21906983 | |
| 59 | Phosphorylation | VKQANKEYLLGSTAE HHHHCHHHHCCCCHH | 14.61 | 20071362 | |
| 63 | Phosphorylation | NKEYLLGSTAEEKAI CHHHHCCCCHHHHHH | 25.14 | 20071362 | |
| 68 | Ubiquitination | LGSTAEEKAIVQQWL CCCCHHHHHHHHHHH | 34.61 | 21963094 | |
| 88 | Ubiquitination | QVDGHSSKNDIHTLL EECCCCCHHHHHHHH | 62.75 | 27667366 | |
| 93 | Phosphorylation | SSKNDIHTLLKDLNS CCHHHHHHHHHHHHH | 33.83 | 20873877 | |
| 96 | Acetylation | NDIHTLLKDLNSYLE HHHHHHHHHHHHHHC | 64.38 | 26822725 | |
| 96 | Ubiquitination | NDIHTLLKDLNSYLE HHHHHHHHHHHHHHC | 64.38 | - | |
| 101 | Phosphorylation | LLKDLNSYLEDKVYL HHHHHHHHHCCCEEE | 17.03 | - | |
| 136 | Acetylation | VDLTVQEKEKYLNVS HCCCHHHHHHHHCHH | 42.27 | 26051181 | |
| 138 | Ubiquitination | LTVQEKEKYLNVSRW CCHHHHHHHHCHHHH | 67.13 | 29901268 | |
| 138 | 2-Hydroxyisobutyrylation | LTVQEKEKYLNVSRW CCHHHHHHHHCHHHH | 67.13 | - | |
| 138 | Malonylation | LTVQEKEKYLNVSRW CCHHHHHHHHCHHHH | 67.13 | 26320211 | |
| 138 | Acetylation | LTVQEKEKYLNVSRW CCHHHHHHHHCHHHH | 67.13 | 19608861 | |
| 160 | Phosphorylation | PGIRQHLSSVVFIKN CCHHHHHHEEEEEEC | 20.97 | 22210691 | |
| 161 | Phosphorylation | GIRQHLSSVVFIKNR CHHHHHHEEEEEECC | 28.76 | 22210691 | |
| 166 | Acetylation | LSSVVFIKNRLYTNS HHEEEEEECCCCCCC | 25.26 | 19608861 | |
| 168 | Methylation | SVVFIKNRLYTNSH- EEEEEECCCCCCCC- | 24.86 | - | |
| 170 | Phosphorylation | VFIKNRLYTNSH--- EEEECCCCCCCC--- | 10.71 | 29496907 | |
| 171 | Phosphorylation | FIKNRLYTNSH---- EEECCCCCCCC---- | 34.53 | 29514088 | |
| 173 | Phosphorylation | KNRLYTNSH------ ECCCCCCCC------ | 23.83 | 25849741 |
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of MCA3_HUMAN !! | ||||||
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of MCA3_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of MCA3_HUMAN !! | ||||||
| Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
|---|---|---|---|---|
| SYEP_HUMAN | EPRS | physical | 22939629 | |
| SYK_HUMAN | KARS | physical | 22939629 | |
| SYIC_HUMAN | IARS | physical | 22939629 | |
| SYDC_HUMAN | DARS | physical | 22939629 | |
| SYMC_HUMAN | MARS | physical | 22939629 | |
| SYQ_HUMAN | QARS | physical | 22939629 | |
| SYRC_HUMAN | RARS | physical | 22939629 | |
| AIMP1_HUMAN | AIMP1 | physical | 22863883 | |
| AIMP2_HUMAN | AIMP2 | physical | 22863883 | |
| SYDC_HUMAN | DARS | physical | 22863883 | |
| IF2G_HUMAN | EIF2S3 | physical | 22863883 | |
| ROA2_HUMAN | HNRNPA2B1 | physical | 22863883 | |
| SYIC_HUMAN | IARS | physical | 22863883 | |
| IQGA1_HUMAN | IQGAP1 | physical | 22863883 | |
| CCAR2_HUMAN | CCAR2 | physical | 22863883 | |
| SYMC_HUMAN | MARS | physical | 22863883 | |
| SYQ_HUMAN | QARS | physical | 22863883 | |
| RL13_HUMAN | RPL13 | physical | 22863883 | |
| RL21_HUMAN | RPL21 | physical | 22863883 | |
| RL23A_HUMAN | RPL23A | physical | 22863883 | |
| RL24_HUMAN | RPL24 | physical | 22863883 | |
| RL26_HUMAN | RPL26 | physical | 22863883 | |
| RL27A_HUMAN | RPL27A | physical | 22863883 | |
| RL36_HUMAN | RPL36 | physical | 22863883 | |
| CACO2_HUMAN | CALCOCO2 | physical | 25416956 | |
| NAT9_HUMAN | NAT9 | physical | 25416956 | |
| AIMP1_HUMAN | AIMP1 | physical | 26344197 | |
| SYLC_HUMAN | LARS | physical | 26344197 | |
| RNH2C_HUMAN | RNASEH2C | physical | 26344197 |
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| There are no disease associations of PTM sites. | ||||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| Acetylation | |
| Reference | PubMed |
| "Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, AND MASS SPECTROMETRY. | |
| "Lysine acetylation targets protein complexes and co-regulates majorcellular functions."; Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.; Science 325:834-840(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-12; LYS-138 AND LYS-166, ANDMASS SPECTROMETRY. | |